Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 8
Submit an article Journal homepage
153
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Delayed processing of bone marrow samples reveals a prognostic pattern of NME mRNA expression in cytogenetically normal acute myeloid leukemia

Enrica BachDepartment of Hematology, Oncology and Hemostasiology, University of Leipzig, Germany
,
Rainer KrahlDepartment of Hematology, Oncology and Hemostasiology, University of Leipzig, Germany
,
Thoralf LangeDepartment of Hematology, Oncology and Hemostasiology, University of Leipzig, Germany
,
Frank SchülerDepartment of Hematology, Oncology and Hemostasiology, University of Leipzig, Germany;Department of Hematology, Oncology and Stem Cell Transplantation, Ernst-Moritz-Arndt-University, Greifswald, Germany
,
Haifa Al-AliDepartment of Hematology, Oncology and Hemostasiology, University of Leipzig, Germany
,
Thomas BüchnerDepartment of Hematology, Hemostasiology, Oncology and Pneumology, University of Münster, Germany
,
Torsten HaferlachMLL Munich Leukemia Laboratory, Munich, Germany
,
Gottfried DölkenDepartment of Hematology, Oncology and Stem Cell Transplantation, Ernst-Moritz-Arndt-University, Greifswald, Germany
,
Dietger NiederwieserDepartment of Hematology, Oncology and Hemostasiology, University of Leipzig, Germany
&
Michael CrossDepartment of Hematology, Oncology and Hemostasiology, University of Leipzig, GermanyCorrespondence[email protected]
 show all
Pages 1561-1568 | Received 30 Nov 2011, Accepted 10 Mar 2012, Published online: 23 Apr 2012

References

  • Mrozek K, Marcucci G, Paschka P, . Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? Blood 2007;109:431–448.
  • Schlenk RF, Dohner K, Krauter J, . Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008;358:1909–1918.
  • Marcucci G, Haferlach T, Dohner H. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications. J Clin Oncol 2011;29:475–486.
  • Rockova V, Abbas S, Wouters BJ, . Risk-stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and expression markers. Blood 2011;118:1069–1076.
  • Postel EH, Berberich SJ, Flint SJ, . Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science 1993;261: 478–480.
  • Roymans D, Willems R, Van Blockstaele DR, . Nucleoside diphosphate kinase (NDPK/NM23) and the waltz with multiple partners: possible consequences in tumor metastasis. Clin Exp Metastasis 2002;19:465–476.
  • Boissan M, Dabernat S, Peuchant E, . The mammalian Nm23/NDPK family: from metastasis control to cilia movement. Mol Cell Biochem 2009;329:51–62.
  • Bosnar MH, Bago R, Cetkovic H. Subcellular localization of Nm23/NDPK A and B isoforms: a reflection of their biological function? Mol Cell Biochem 2009;329:63–71.
  • Lombardi D, Lacombe ML, Paggi MG. nm23: unraveling its biological function in cell differentiation. J Cell Physiol 2000;182: 144–149.
  • Yokoyama A, Okabe-Kado J, Sakashita A, . Differentiation inhibitory factor nm23 as a new prognostic factor in acute monocytic leukemia. Blood 1996;88:3555–3561.
  • Murphy KM, Levis M, Hafez MJ, . Detection of FLT3 internal tandem duplication and D835 mutations by a multiplex polymerase chain reaction and capillary electrophoresis assay. J Mol Diagn 2003;5:96–102.
  • Noguera NI, Ammatuna E, Zangrilli D, . Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia. Leukemia 2005;19:1479–1482.
  • Wakimoto N, Yokoyama A, Okabe-Kado J, . Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia. Br J Cancer 1998;77:2298–2303.
  • Yokoyama A, Okabe-Kado J, Wakimoto N, . Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies. Blood 1998;91:1845–1851.
  • Okabe-Kado J, Kasukabe T, Honma Y, . Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinase. Biochem Biophys Res Commun 1992;182:987–994.
  • Tschiedel S, Bach E, Jilo A, . Bcr-Abl dependent post-transcriptional activation of NME2 expression is a specific and common feature of chronic myeloid leukemia. Leuk Lymphoma 2012;53:1569–1576.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.